Treatment of psoriatic arthritis with etanercept [1]

Journal of the American Academy of Dermatology

Volumn 44, Issue 6, 2001, Pages 1052-

  Kurschat, P ^a   Rubbert, A ^a   Poswig, A ^a   Scharffetter Kochanek, K ^a   Krieg, T ^a   Hunzelmann, N ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETANERCEPT; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CASE REPORT; DRUG EFFICACY; HUMAN; INFLAMMATION; LETTER; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; TREATMENT OUTCOME;

EID: 0035010091     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.112353     Document Type: Letter

References (3)

1. The role of cytokines in rheumatoid arthritis
2. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
3. A trial of etanercept, a recombinant tumor necrosis factor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate